CollPlant Biotechnologies
CLGN
CLGN
20 hedge funds and large institutions have $14.3M invested in CollPlant Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less capital invested
Capital invested by funds: $19.5M → $14.3M (-$5.14M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Holders
20
Holding in Top 10
1
Calls
–
Puts
$4K
Top Buyers
| 1 | +$361K | |
| 2 | +$189K | |
| 3 | +$139K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$103K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$65.1K |
Top Sellers
| 1 | -$783K | |
| 2 | -$28.2K | |
| 3 | -$9K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1K |